Together, Let's Make Digital Pathology a Ubiquitous Reality
Huron Innovation in the Spotlight
Management and Board
Audil Virk is the President of Huron Digital Pathology, with more than 15 years of progressively responsible experience, having started his career with Huron as the head of software development. In his current role, Audil is responsible for strategic planning and execution, budget planning, staff development, and cost reductions with quality improvements. Audil directs the day-to-day operations, guides product development, and works closely with the sales team.
Prior to Huron, Audil worked in the telecommunications industry for Mitel Networks, where he was an inventor of two software patents on managing log files. He holds a BSc in Biochemistry from Queen’s University and a diploma in Computer Engineering Technology from Saint Lawrence College.
Savvas become Chief Technology Officer for Huron in 2010. He joined the company (originally known as Biomedical Photometrics Inc.) in 1998 as project leader. He led the development and manufacturing of micro array readers, tissue imaging systems, and a MacroScope/Microscope combination system for general confocal imaging applications. He has been involved in the development of imaging systems for more than 20 years and is the author of several patents and more than 30 publications on confocal microscopy imaging techniques and applications.
Savvas Damaskinos received his Ph.D. in Physics from the University of Waterloo in 1985 and was the first recipient of the GWP Pearson medal for graduate work in Physics. He spent three years at the Institute of Energy Conversion in Delaware, a centre of excellence for photovoltaics, returning to the Department of Physics at the University of Waterloo as a Research Associate Professor in 1988. Research activities at the Physics Department resulted in several patents in the area of confocal scanning laser imaging technology.
savvas.chamberlain@exelresearch.com
Savvas Chamberlain a Distinguished Professor Emeritus of the University of Waterloo is presently the CEO and Chairman of EXEL Research Inc. a company which provides services to identify and commercialize innovations arising from university research. This company also invests in promising young high tech companies in Canada.
Savvas was born in Dhikomo, Cyprus, of Greek Cypriot heritage. He was educated in England, received his first degree in London, and his M.Sc. and Ph.D. degrees from Southampton University. After his Ph.D. in 1968 he worked briefly with Plessey Research Laboratories in Caswell, and then immigrated in 1969 to Canada. In 1974 he became a proud Canadian Citizen. In July 2009 Savvas was inducted into the Order of Canada. He is a resident of Ontario. In 1980 he founded DALSA, a successful Semiconductor and Electronics company in Canada.
Mike is President of Pinnacle Capital Partners, a self-funded private equity group. He spends most of his time managing the portfolio of companies, completing acquisitions, and serving on the board of directors of investee companies.
He started his career working in public accounting with Zittrer Siblin Stein Levine (merged with EY in 1988) before joining the Canada Revenue Agency in Kitchener from 1988 to 1999 as a tax auditor and then as a Senior Business Valuator. In 1999 he returned to public accounting for one year before venturing out in 2000 to co-find Pinnacle Capital Partners, offering services in mergers and acquisitions, financings and divestitures.
Mike studied at Wilfrid Laurier University obtaining an Honors Business Administration degree with an option in Economics in 1987. He continued his studies while working, obtaining the designation of Chartered Business Valuator (CBV) in 1997 and Chartered Financial Analyst (CFA), designation in 2001.
Ted is a co-founder of Biomedical Photometrics Inc., the predecessor to Huron Digital Pathology. He is also Professor Emeritus, Department of Physics and Astronomy, University of Waterloo. He invented Huron’s Moving Specimen Image Averaging (MSIA) technology, and continues to lead Huron’s patent development and application process. He is the inventor or co-inventor of 19 US Patents and several International patents plus US and International patents pending.
He was a Director of the Centre for Imaging Technology Commercialization (CIMTEC), and a member of the Council of Canadian Academies’ Expert Panel on the Socio-economic Impact of Innovation Investments. He was a member of the Advisory Board of the National Research Council Canada’s Steacie Institute for Molecular Sciences, a Director of DALSA Corp., a Principal Investigator in Photonics Research Ontario, co-Founder and CEO of Biomedical Photometrics Inc. (now Huron Digital Pathology), and Founder, CEO and Chairman of Waterloo Scientific Inc.
At the University of Waterloo, Ted’s research focused on the development and commercial application of scanning laser imaging technology. An early patent supported the founding of Waterloo Scientific in 1983, and the development of additional patented technologies and applications supported the founding of Biomedical Photometrics in 1994.
Ted was awarded the Canadian Association of Physicists / National Optics Institute Medal for Outstanding Achievement in Applied Photonics in 2006.
Christine Chamberlain is Vice-President of Operations at EXEL Research Inc., a company based in Waterloo Ontario which focusses on investment in small to medium sized companies, primarily in southwestern Ontario, and also manages commercial and vacation rental properties. She began working with EXEL in May 2004.
From September 1996 to April 2004, she was Manager of Undergraduate Processing at the Ontario Universities Application Centre (OUAC) in Guelph Ontario, managing the processing of undergraduate applications to all Ontario universities for applicants from Ontario, from Canada and from international applicants. She began her career in 1981 at Wilfrid Laurier University in Office of the Registrar, ultimately as Assistant Registrar, Admissions.
Christine’s skills are primarily focussed on the management of human resources/personnel in companies and on efficient, accountable and responsible operations. She holds a Bachelor of Music degree from Wilfrid Laurier University and has, as well, completed a number of business courses at the same institution’s School of Business and Economics.
Christine is a member of the Board of Directors and secretary of the Savvas Chamberlain Family Foundation www.scffoundation.com . She is a past member of the board of directors of the Kitchener-Waterloo Symphony (KWS), a past member of the Wilfrid Laurier University President’s Regional Council of Advisors, and a current member of the President’s Advisory Council of the KWS.
Christine is a proud Canadian who strives to help the underprivileged and to support arts and culture. She has many interests, but most enjoys outdoor activities, music (classical, jazz, contemporary), gardening, world travel and her three cats.
Brian is the retired CEO of Teledyne DALSA, one of Canada’s most successful imaging technology companies and OEM supplier of digital imaging components to the medical, scientific, and industrial markets.
Our History
2020
Granted its first US patent for barcoding digital images.
Commercial availability of the Lagotto image search engine, with API to integrate with 3 party image management systems
2019
Launches ‘Scan Index Search platform.
Launch TissueScope iQ with real time indexing.
First commercial prototype of image search engine.
2016
Introduce TissueScope LE120 for medium volume slide scanning.
Launch TissueScope PE desktop slide scanner
2014
Introduce patented TissueSnap preview station and workflow tool
Launch TissueScope LE, best-in-class slide scanner for low-volume labs
2013
Receive Frost & Sullivan’s 2013 Product Excellence Award in Slide Scanners
Launch TissueScope HS Scanner and TissueView software
2012
TissueScope awarded 1st prize in two categories (20X Fluorescence and 40X Fluorescence) at the 2nd International Scanner Contest
2011
Launch TissueScope Autoloader for continuous operation and automated workflow
2010
Receive injection of new capital from investors Savvas Chamberlain and Mike Panayi. Company name changed from Biomedical Photometrics Inc. to Huron Technologies Inc.
2009
2007
Introduce 1st generation TissueScope multi-slide holder scanner for brightfield and fluorescence imaging of microscope slides
2006
2005
Launch first TissueScope scanner for brightfield and fluorescence imaging of microscope slides
2004
2003
2002
Introduce 3rd generation DNAscope scanner for DNA microarrays
2001
2000
Launch 2nd generation DNAscope scanner for DNA microarrays
1999
1998
Develop first DNAscope scanner for DNA microarrays
1997
1996
1995
1994
Biomedical Photometrics Inc. founded to commercialize scanning laser imaging technology developed at the University of Waterloo.
Our Customers













